Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
- Company Name: Novartis AG
- Country/Region: Switzerland
- ISIN: CH0012005267
- Listing Date:
- Industry: Health Care / Pharmaceuticals